Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia

Medical Research Council Working Party. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981;i:681–6.

Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic lung disease: a clinical trial. Ann Intern Med 1980;93:391–8.

Skwarski K, MacNee W, Wraith PK, Sliwinski P, Zielinski J. Predictors of survival in patients with chronic obstructive pulmonary disease treated with long-term oxygen therapy. Chest 1991;100:1522–7.

Dubois P, Jamart J, Machiels J, Smeets F, Lulling J. Prognosis of severely hypoxemic patients receiving long-term oxygen therapy. Chest 1994;105:469–74.

Zielinski J, Sliwinski P. Indications and methods of longterm oxygen therapy. Eur Respir Rev 1991;1:536–40.

Levi Valensi P, Aubry P, Donner CF, Robert B, Ruhle KH, Weitzenblum E for the task group of SEP. Recommendations for long term oxygen therapy. Eur Respir J 1989;2:160–4.

Conference Report. Further recommendations for prescribing and supplying long-term oxygen therapy. Am Rev Respir Dis 1988;138:745–7.

Strom K, Boe J. A national register for long-term oxygen therapy in chronic hypoxia: preliminary report. Eur Respir J 1988;1:952–8.

Gorecka D, Sliwinski P, Zielinski J. Adherence to entry criteria and one year experience of long-term oxygen therapy in Poland. Eur Respir J 1992;5:848–52.

Zielinski J, Sliwinski P, Tobiasz M, Gorecka D. Long-term oxygen therapy in Poland. Monaldi Arch Chest Med 1993; 48:479–80.

Cox DR. Regression model and life tables. IR Stat Soc (Series B) 1972;34:187–200.

Timms RM, Khaja FU, Williams GW. The Nocturnal Oxygen Trial Group. Haemodynamic response to oxygen therapy in chronic obstructive pulmonary disease. Ann Intern Med 1985;102:29–36.

Weitzenblum E, Sautegeau A, Ehrhart M, Mammosser M, Pelletier A. Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1985;131:493–6.

Tobiasz M, Sliwinski P, Hawrytkiewicz I, Patasiewicz G, Zielinski J. Pulmonary haemodynamics after 6 years of oxygen therapy in COPD. Am J Respir Crit Care Med 1995;151:A255.

Weitzenblum E, Oswald M, Apprill M, Ratomaharo J, Kessler R. Evolution of physiological variables in patients with chronic obstructive pulmonary disease before and during long-term oxygen therapy. Respiration 1991;58: 126–31.

Cooper CB, Howard P. An analysis of sequential physiologic changes in hypoxic cor pulmonale during long-term oxygen therapy. Chest 1991;100:76–80.

Sliwinski P. Effects of long-term oxygen therapy in patients with chronic obstructive pulmonary disease. Pneumonol Alergol Pol 1992;60:20–7.

Barjhoux C, Pepin JL, Deschaux-Blanc C, et al. Oxygenotherapie au long cours a domicile. Respect de la prescription medicale et observance d’une duree quotidienne d’au moins 15 heures. Rev Mal Resp 1994;11: 37–45.

Strom K, Boe J. The Swedish Society of Chest Medicine: quality assessment and predictors of survival in long-term domiciliary oxygen therapy. Eur Respir J 1991;4:50–8.

Chailleux E, Binet F, Sadoul P et Commission MedicoTechnique et Sociale de L’ANTADIR. Facteurs pronostiques de la survie des insuffisants respiratoires obstructifs traites par oxygenotherapie a long terme. Rev Mal Resp 1992;9:603–11.

Anthonisen NR, Wright EC, Hodgkin JE, and the IPPB Trial group. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986;133:14–20.

Anthonisen NR. Prognosis in chronic obstructive pulmonary disease:results from multicenter clinical trials. Am Rev Respir Dis 1989;140:S95–9.

The Drug Tariff. Introduction of oxygen concentrators to the domiciliary oxygen therapy service. Publication No. FNP 398. London: Department of Health and Social Security, 1986.

Dallari R, Barozzi G, Pinelli G, Merighi V, Grandi P, Manzotti M, et al. Predictors of survival in subjects with chronic obstructive pulmonary disease treated with longterm oxygen therapy. Respiration 1994;61:8–13.

Vanderbergh E, Van de Woestyne KP, Gyselen A. Weight changes in the terminal stages of chronic obstructive pulmonary disease. Am Rev Respir Dis 1967;95:556–66.

Wilson DO, Rogers RM, Wright EC, Anthonisen NR. Body weight in chronic obstructive pulmonary disease. Am Rev Respir Dis 1989;139:1435–8.

Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977;1:1645–8.

Anthonisen NR, Connet JE, Kiley JP, et al for the Lung Health Study Research Group. Effects of smoking intervention and use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. JAMA 1994;272: 1497–505.

Postma DS, Sluiter HJ. Prognosis of chronic obstructive pulmonary disease: the Dutch experience. Am Rev Respir Dis 1989;140:S100–5.

Strom K. Survival of patients with chronic obstructive pulmonary disease receiving long-term oxygen therapy. Am Rev Respir Dis 1993;147:585–91.